Xolair 150 MG/ML autoinjectorml
Ended Awarded
- Contract number
- SPE2DB26FUJMB
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,818
Award facts
- Contract value 100% obligated
- $12,817.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $12,817.80 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xolair 150 mg/ml autoinjectors. The delivery order, which carries no set-aside designation, is scheduled for completion by November 25, 2025, and was issued on November 3, 2025. DMS Pharmaceutical Group is performing the work at its headquarters location in Park Ridge, Illinois.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a $30.3 billion government-wide acquisition strategy that establishes multiple regional prime vendor contractors to supply pharmaceutical products and medical consumables to Department of Defense healthcare facilities worldwide. The parent contract, valued at $499,999,999 with an ultimate completion date of December 31, 2036, authorizes the issuance of firm fixed-price delivery orders for branded and generic prescription medications, biologics, vaccines, and medical consumables. DMS Pharmaceutical Group has demonstrated substantial federal contracting capability through numerous prior delivery orders across diverse therapeutic categories and continues to serve as a critical supplier within the federal pharmaceutical supply chain for military healthcare operations.
Quick answers
Who was awarded contract SPE2DB26FUJMB?
SPE2DB26FUJMB was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 3, 2025.
How much is contract SPE2DB26FUJMB worth?
The government has obligated $12,818 on SPE2DB26FUJMB.
Is contract SPE2DB26FUJMB an order under another contract?
Yes. SPE2DB26FUJMB is a delivery order under SPE2DB25D9365, an indefinite delivery contract.
Was contract SPE2DB26FUJMB competed?
The extent of competition for SPE2DB26FUJMB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award